Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • alyse_c
    replied
    Tomorrow is the last day to submit your results for the NCTR Indel Calling from Oncopanel Sequencing Data Challenge! Phase 1 closes on July 8th. The optional Phase 2 is open for only those who have completed Phase 1 and will run from July 11th-July 26th.

    Submit your results here: https://go.usa.gov/xSc6t


    Originally posted by alyse_c View Post
    There are only a few days left to submit your results for the NCTR Indel Calling from Oncopanel Sequencing Data Challenge! Phase 1 closes on July 8th. Those who completed Phase 1 for both Oncopanel A & Oncopanel B will be able to participate in the optional Phase 2 that runs from July 11th-July 26th.

    Visit the site below to submit your final results!
    https://go.usa.gov/xJzdB



    Leave a comment:


  • alyse_c
    replied
    There are only a few days left to submit your results for the NCTR Indel Calling from Oncopanel Sequencing Data Challenge! Phase 1 closes on July 8th. Those who completed Phase 1 for both Oncopanel A & Oncopanel B will be able to participate in the optional Phase 2 that runs from July 11th-July 26th.

    Visit the site below to submit your final results!
    https://go.usa.gov/xJzdB


    Originally posted by alyse_c View Post
    Reminder! We are less than one month out from the NCTR Indel Calling from Oncopanel Sequencing Data Challenge submission deadline! There’s still time to join the challenge.

    This challenge is being hosted in collaboration with the FDA’s National Center for Toxicological Research (NCTR) and is taking part in two phases.

    Phase 1 of the challenge will run through July 8th and Phase 2 will run from July 11th-July 26th.

    The primary goal of this challenge is to encourage the bioinformatics community to develop, validate, and benchmark indel calling pipelines to identify indels in oncopanel sequencing datasets. Given the widely recognized impact of indels on protein coding and function, it is crucial that the tools for indel-calling be rigorously evaluated and optimized.

    Winners of the challenge will be publicly recognized and invited to contribute to a manuscript and a webinar describing the challenge and their submission results. Visit the challenge site below to get started or to submit your results!

    https://go.usa.gov/xJw8B

    Leave a comment:


  • PrecisionFDA's NCTR Indel Calling from Oncopanel Sequencing Data Challenge

    Reminder! We are less than one month out from the NCTR Indel Calling from Oncopanel Sequencing Data Challenge submission deadline! There’s still time to join the challenge.

    This challenge is being hosted in collaboration with the FDA’s National Center for Toxicological Research (NCTR) and is taking part in two phases.

    Phase 1 of the challenge will run through July 8th and Phase 2 will run from July 11th-July 26th.

    The primary goal of this challenge is to encourage the bioinformatics community to develop, validate, and benchmark indel calling pipelines to identify indels in oncopanel sequencing datasets. Given the widely recognized impact of indels on protein coding and function, it is crucial that the tools for indel-calling be rigorously evaluated and optimized.

    Winners of the challenge will be publicly recognized and invited to contribute to a manuscript and a webinar describing the challenge and their submission results. Visit the challenge site below to get started or to submit your results!

    https://go.usa.gov/xJw8B
    Last edited by alyse_c; 06-22-2022, 01:18 PM.

Latest Articles

Collapse

  • SEQadmin2
    How Immunogenomics Decodes Immunity’s Genetic Blueprint
    by SEQadmin2




    The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.

    This convergence of genetics, immunology, and computation...
    09-01-2026, 05:41 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 09:06 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 09-23-2026, 11:05 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 09-18-2026, 11:37 AM
1 response
38 views
0 reactions
Last Post pekgio
by pekgio
 
Started by SEQadmin2, 09-16-2026, 10:23 AM
1 response
55 views
0 reactions
Last Post pekgio
by pekgio
 
Working...